Expiry of patent protection on statins: effects on pharmaceutical expenditure in Australia-Reference-Cited by-同舟云学术

Expiry of patent protection on statins: effects on pharmaceutical expenditure in Australia

Published:2011-01 Issue:1 Volume:194 Page:52-54
ISSN:0025-729X
Container-title:Medical Journal of Australia
language:en
Short-container-title:Medical Journal of Australia

Author:

Clarke Philip M¹,Fitzgerald Edmund M¹

Affiliation:

1. School of Public Health, University of Sydney, Sydney, NSW.

Publisher

AMPCo

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.5694/j.1326-5377.2011.tb04157.x

Reference4 articles.

1. Expiry of patent protection on statins: effects on pharmaceutical expenditure in Australia

2. Ontario Ministry of Health and Long‐Term Care. Update R1 Ontario Drug Benefit Formulary/Comparative Drug Index No. 41. Effective June 18 2010. Summary of changes.http://www.health.gov.on.ca/english/providers/program/drugs/formulary/41_update_r1_20100608.pdf(accessed Sep 2010).

3. Memorandum of Understanding between the Australian Government and Medicines Australia.http://www.health.gov.au/internet/main/publishing.nsf/Content/C6EC4D1258BBFFB6CA257721000520A2/$File/MOU%20MA.pdf(accessed Sep 2010).

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. OBSOLETE: Health systems of Australia and New Zealand;Reference Module in Biomedical Sciences;2019

2. Health Systems of Australia and New Zealand;International Encyclopedia of Public Health;2017

3. Generic drug prices and policy in Australia: room for improvement? A comparative analysis with England;Australian Health Review;2014

4. Improving the cost-effectiveness of cardiovascular disease prevention in Australia: a modelling study;BMC Public Health;2012-06-01

5. Challenges and opportunities for the Pharmaceutical Benefits Scheme;Medical Journal of Australia;2012-02